Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
A compared with HBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
A
Agilent Technologies, Inc.
Change
Mkt cap
Revenue
Revenue
HBIO
Harvard Bioscience Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
A
Agilent Technologies, Inc.
vs
HBIO
Harvard Bioscience Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only A
2
ALNY
Alnylam Pharmaceuticals
customer
WGS
GeneDx
customer
Shared
0
No shared counterparties.
Only HBIO
1
—
Harvard University
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
A
Agilent Technologies, Inc.
Change
174.77
▲
+1.74%
· post 175.00
Mkt cap
$49.3B
Revenue
$1.9B
Q3 FY26
Revenue
$6.9B
FY25
HBIO
Harvard Bioscience Inc
Change
8.38
▼
−0.95%
· post 8.38
Closed
Nov 6 '26
Mkt cap
$38.1M
Revenue
$23M
Q2 FY26
Revenue
$87M
FY25
vs
Compare
Closed
Nov 6 '26
A
Agilent Technologies, Inc.
vs
HBIO
Harvard Bioscience Inc
174.77
▲
+1.74%
post 175.00
Price
8.38
▼
−0.95%
post 8.38
$49.3B
Mkt cap
$38.1M
Q3 FY26
$1.9B
Revenue
$23M
Q2 FY26
FY25
$6.9B
Revenue
$87M
FY25
Change
Change
A
174.77
▲
+1.74%
vs
HBIO
8.38
▼
−0.95%
Closed
Nov 6 '26